Assertio Holdings (FRA:DPOA) Current Accrued Expense : €66.1 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Assertio Holdings Current Accrued Expense?

Assertio Holdings's Current Accrued Expense for the quarter that ended in Mar. 2024 was €66.1 Mil.

Assertio Holdings's quarterly Current Accrued Expense declined from Sep. 2023 (€72.8 Mil) to Dec. 2023 (€67.8 Mil) and declined from Dec. 2023 (€67.8 Mil) to Mar. 2024 (€66.1 Mil).

Assertio Holdings's annual Current Accrued Expense declined from Dec. 2021 (€56.0 Mil) to Dec. 2022 (€55.2 Mil) but then increased from Dec. 2022 (€55.2 Mil) to Dec. 2023 (€67.8 Mil).

Assertio Holdings Current Accrued Expense Historical Data

The historical data trend for Assertio Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assertio Holdings Current Accrued Expense Chart

Assertio Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

72.07

71.09

55.97

55.21

67.78

Assertio Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															58.38	48.02	72.77	67.78	66.07

Assertio Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Assertio Holdings Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Assertio Holdings's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Assertio Holdings (FRA:DPOA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Assertio Holdings Inc (FRA:DPOA) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

ASRT:USA

Address

100 South Saunders Road, Suite 300, Lake Forest, IL, USA, 60045

Website

https://www.assertiotx.com

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Assertio Holdings (FRA:DPOA) Headlines

No Headlines